Showing posts with label
Autoimmmune disease
.
Show all posts
Showing posts with label
Autoimmmune disease
.
Show all posts
Friday, August 8, 2025
Here’s the latest on Cabaletta Bio Inc. (NASDAQ: CABA) as August 2025
›
Why CABA Could “Pop” with Catalysts This Summer 1. Clear Regulatory Path & BLA Target Cabaletta secured RMAT designation and recently a...
›
Home
View web version
